Advanced CancerNCT00625742
Multimodal Treatment Strategy for Cancer Cachexia
A study testing Graded Resistance Training, Aerobic Exercise and Melatonin in people with Advanced Cancer and Cachexia, run by M.D. Anderson Cancer Center at 1 site in United States.
Trial summary
The primary aim of this proposal is to present a novel, multimodal treatment strategy for increasing lean body mass in individuals with cancer who experience cachexia between baseline and day 29 (+/- 3 days). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Advanced Cancer, Cachexia
- What is being tested?
- Graded Resistance Training, Aerobic Exercise and Melatonin
- Type of treatment
- Pill or oral medicine, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 15 participants
- Where
- 1 siteUnited States
- Study dates
- Feb 2008to Jun 2014
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Are referred to the Cachexia Clinic with involuntary weight loss of >5% of their premorbid weight within the previous 6 months.
- Are 18 years of age or older
- Have a Karnofsky performance score of 60 or higher.
- Can maintain oral food intake during the study
- Can understand the study procedures and can sign an informed consent form.
- Are not currently taking melatonin.
- Are taking megestrol acetate and continue to lose weight despite at least 2 weeks of therapy.
- Have a calculated creatinine clearance of >/= 60 cc/min.
Who cannot join
- Have dementia or delirium (as determined by the palliative care specialist) at study entry.
- Are pregnant
- Have been taking corticosteroids for longer than 48 hours.
- Have pulmonary edema, ascites or pitting edema on clinical examination.
- Are unable to walk.
- Have a history of serious adverse gastrointestinal events (i.e., bleeding or perforation),history of a coagulopathy or current anti-coagulant use.
Show all 9Show fewer
- Have an ALT/AST>3x upper limit of normal.
- Patients on methotrexate.
- Patients taking melatonin receptor agonists (such as Rozerem® [ramelteon]).
Trial locations and contacts
1 site in 1 country.
About this study
Official title: An Exploratory Trial of a Multimodal Treatment Strategy for Cancer Cachexia
The primary aim of this proposal is to present a novel, multimodal treatment strategy for increasing lean body mass in individuals with cancer who experience cachexia between baseline and day 29 (+/- 3 days). The strategy includes graded resistance training and aerobic exercise, targeted nutrient supplementation and pharmacologic intervention (melatonin).
We postulate that this strategy, together with the simultaneous management of symptoms that decrease appetite (e.g. depression, pain, and nausea), will also accomplish our secondary objectives of improving clinical outcomes such as strength and function between baseline and day 29 (+/- 3 days).
Read the detailed description
The Study Drugs:
Melatonin is a hormone that helps reduce inflammation and poor food absorption caused by cancer. It may also enhance the effects of ibuprofen.
Juven is a nutritional supplement that is designed to help build muscle and slow muscle breakdown.
Screening Tests:
Before you can start treatment on this study, you will have "screening tests" to help the doctor decide if you are eligible to take part in this study. The following tests will be performed:
- Blood (1 to 2 tablespoons) will be drawn for routine tests. This routine blood draw will include a pregnancy test for women who are able to have children. To be eligible to take part in this study, the pregnancy test must be negative.
- Additional blood (1 tablespoon) will be drawn to check your thyroid function and the levels of two B vitamins, if these have not been checked within the past 3 months.
- You will have a physical exam, including measurement of vital signs (blood pressure, heart rate, temperature, and breathing rate).
- You will have an electrocardiogram (ECG -- a test that measures the electrical activity of the heart).
- Your resting energy expenditure (energy used at rest) will be measured. with a calorie-measuring device. For this test, you will breathe in and out through your mouth for about 10 minutes to allow a calorie-measuring device to measure the oxygen your body uses, and from this it calculates how much energy your body uses at rest.
- You will be asked to fill out a questionnaire to rate your overall physical well-being, another questionnaire to rate your level of fatigue, and a third questionnaire to rate your experiences with 10 common symptoms in the past 24 hours (pain, fatigue, nausea, depression, anxiety, drowsiness, shortness of breath, changes in appetite, sleep difficulty, and feeling of well being). In total, these questionnaires will take about 30 minutes to complete.
- You will complete a diary entry that lists all of the food and drinks you have had in the last 3 days. It should take about 10 minutes to complete.
- Your strength and stamina will be evaluated. This is measured by hand-grip and pinch strength tests that are done with both hands. These tests will see how hard you can grip a device with your hand and pinch the pads of another device called a pinch gauge. These tests will be done 3 times and your best scores will be used. Your strength and stamina will also be checked using the Get-Up-and-Go test and the 6-minute walk test. The Get-Up-and-Go test measures how long it takes to get up from sitting in a chair that has arms, walking 10 feet, turning around and walking back to the chair, and sitting down. The 6-minute walk test will measure the distance you can walk in 6 minutes on a 100-foot loop. You will walk 50 feet and then turn and walk back to the beginning. You will do this at a walking speed that feels comfortable and for as many times as you can in 6 minutes.
- Blood (1 to 2 tablespoons) will be drawn to check for markers of inflammation and nutrition status.
Study Drug Administration:
You will take one (1) 20mg capsule of melatonin every night. It can be taken with or without food. It should be taken with 8 ounces (1 cup) of water.
You will drink 90 calories of Juven, twice a day. Juven is a powder supplement that is mixed into 8 ounces of water. It is available in orange or grape flavors.
You will also be instructed to increase your daily calorie intake by at least 1,000 calories. To assist you in doing so, dietary advice will be given to you by a nurse or physician.
Exercise Training:
You will complete 2 exercise training sessions a week. The sessions will combine resistance and graded aerobic training.
Resistance training (with Thera-bands) is designed to increase the muscle-building effects of a hormone called testosterone. Thera-bands are rubber bands that you can hold or put around your feet to provide resistance to your muscles when you bend and flex your arms and legs.
You will be instructed in how to do 3 upper-body exercises (chest press, shoulder press, and arm pull down) and 3 lower-body exercises (leg press, leg extension, and leg flexion).
At your first visit, a physician will educate you to make sure that all exercises are done correctly.
Each repetition will take 12 seconds to complete (6 seconds to bend, then 6 seconds to straighten your arm or leg). When 6 repetitions are completed, the next week's set will be increased by 1 repetition.
Graded aerobic exercise is a walking/running program that may help you exercise longer.
Graded aerobic exercise involves walking or running for 3-4 minutes at 70-80% of your maximum predicted heart rate. There will be a 3-minute warm-up and a 3-minute cool-down before and after this exercise.
During your first visit, you will be shown how to monitor your heart rate and how to exercise at 70-80% of your maximum heart rate.
You will add 1 minute to your aerobic exercise at the start of each week.
You will receive your own customized aerobic and resistance exercise program based on your range of motion and risk for falls, which will be evaluated by the study staff.
If you experience chest pain, have a temperature over 100.4 °F, have a platelet count of lower than a certain level, have fresh bruises, or shortness of breath at rest, you will be advised to stop exercising until these are relieved.
Evaluations:
While on study, within 3 days of the days listed below, the following measurements will be monitored:
- Your lean body mass and weight will be checked at Days 15 and 29 using the Tanita TBF-310 body composition analyzer/scale. For measurements with the Tanita TBF 310, you will be asked to wear light clothes and to take off your shoes and socks when being weighed. You will stand on a special scale that will send an extremely low-energy, high-frequency electrical signal from one foot to your other foot. You should not be able to feel this at all.
- Your muscle mass (mid-arm muscle area) will be measured with a special tape.
- The thickness of a skin fold on your triceps (back of your upper arm) will be measured 3 times using skin fold calipers. Calipers are a gentle clamp-like device that is used on the outside of your body to measure skin thickness.
- At Day 29, your resting energy expenditure will be measured.
- On Days 15 and 29 of the study cycle, you will complete the same 3 questionnaires as at screening.
- Your caloric intake will be measured on Days 15 and 29.
- Your strength and stamina will be evaluated on Days 15 and 29.
- On Day 29, blood (1 to 2 tablespoons) will be drawn to check for markers of inflammation and nutrition.
- Blood (about 1 to 2 tablespoons) will be drawn for routine tests every 15 days while you are on-study. You will also have a fecal occult blood test at this time.
Length of Study:
You will be on study for 29 days (1 cycle).
This is an investigational study. Melatonin and Juven are commercially available nutritional supplements and are exempt from FDA approval. However, in patients with cancer and cachexia, the study treatment (resistance training, aerobic exercise, and the use of Juven, and melatonin) is considered experimental. At this time, it is only being used in research.
Up to 40 patients will be enrolled on this study. Up to 30 patients will be enrolled at M.D. Anderson, and 10 will be enrolled at the University of Alabama-Birmingham.
- Conditions
- Advanced Cancer, Cachexia
- Being tested
- Graded Resistance Training, Aerobic Exercise, Melatonin, Juven, Atenolol
- Keywords
- Advanced Cancer, Cancer Cachexia, Cachexia, Melatonin, Juven, Exercise Training, Weight Loss
- Medical subject headings
- Cachexia, Weight Loss
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Graded Resistance TrainingBehavioural
Resistance training sessions twice weekly using Thera-bands.
Aerobic ExerciseBehavioural
Walking or running for 3-4 minutes at 70-80% of your maximum predicted heart rate.
MelatoninDrug
20 mg by mouth (PO) Daily
JuvenDietary supplement
90 calories of Juven, twice a day.
AtenololDrug
Atenolol will only be taken if there's evidence of increased sympathetic activity (resting heart rate >110 beats/min) or resting energy expenditure (REE) > 110% of predicted.
IbuprofenDrug
Ibuprofen 1200mg/day in three divided doses.
| Study group | Role | What they receive |
|---|---|---|
| Multimodal Treatment Strategy | Experimental | Exercise Program + Pharmacologic Intervention (Melatonin + Atenolol + Ibuprofen) + Nutritional Supplementation (Juven) - Resistance training sessions twice weekly using Thera-bands. Walking or running for 3-4 minutes at 70-80% of maximum predicted heart rate. Melatonin 20 mg by mouth (PO) Daily. 90 calories of Juven, twice a day. Receives: Behavioral: Graded Resistance Training; Behavioral: Aerobic Exercise; Drug: Melatonin; Dietary Supplement: Juven; Drug: Atenolol; Drug: Ibuprofen |
What is being measured
The primary outcome is the main question the study is designed to answer.
Participant Gain in Lean Body Mass
Measure increases in lean body mass in individuals with cancer who experience cachexia between baseline and day 29 (+/- 3 days).
Measured: Baseline to Day 29, approximately 30 days
Secondary outcomes (1)
Improvement of Clinical Outcomes
Improvement of clinical outcomes such as strength and function between baseline and day 29 (+/- 3 days).
Measured: Baseline to Day 29, approximately 30 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Feb 2008 (estimated)
- Study startFeb 2008
- Primary completionJun 2014
- Study completionJun 2014
Why it stopped: Low Accrual
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Advanced CancerStudies of the same condition, open and under way.
- More trials run by M.D. Anderson Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 15 participants (actual)
Sponsor and investigators
- Lead sponsor
- M.D. Anderson Cancer Center
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Rony Dev, DO, Principal investigator, M.D. Anderson Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00625742
- Sponsor's protocol ID
- 2006-0739
- Other IDs
- NCI-2012-01744
- Status last verified
- Jan 2016
- First submitted
- 19 Feb 2008
- Last updated
- 12 Feb 2016
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Feb 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- An Exploratory Trial of a Multimodal Treatment Strategy for Cancer Cachexia
- ClinicalTrials.gov ID
- NCT00625742
- Acronym / sponsor ID
- 2006-0739
- Conditions
- Advanced Cancer, Cachexia
- Keywords
- Advanced Cancer, Cancer Cachexia, Cachexia, Melatonin, Juven, Exercise Training, Weight Loss
- Study type
- Interventional
- Recruitment status
- TerminatedReason stopped: Low Accrual
- Enrolment
- 15 participants (actual)
- Lead sponsor
- M.D. Anderson Cancer CenterUniversity, hospital or other
- Study start
- Feb 2008
- Primary completion
- Jun 2014 (actual)
- Study completion
- Jun 2014 (actual)
- First posted
- 28 Feb 2008 (estimated)
- Results
- Posted 12 Feb 2016
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary aim of this proposal is to present a novel, multimodal treatment strategy for increasing lean body mass in individuals with cancer who experience cachexia between baseline and day 29 (+/- 3 days). The strategy includes graded resistance training and aerobic exercise, targeted nutrient supplementation and pharmacologic intervention (melatonin).
We postulate that this strategy, together with the simultaneous management of symptoms that decrease appetite (e.g. depression, pain, and nausea), will also accomplish our secondary objectives of improving clinical outcomes such as strength and function between baseline and day 29 (+/- 3 days).
Detailed description
The Study Drugs:
Melatonin is a hormone that helps reduce inflammation and poor food absorption caused by cancer. It may also enhance the effects of ibuprofen.
Juven is a nutritional supplement that is designed to help build muscle and slow muscle breakdown.
Screening Tests:
Before you can start treatment on this study, you will have "screening tests" to help the doctor decide if you are eligible to take part in this study. The following tests will be performed:
- Blood (1 to 2 tablespoons) will be drawn for routine tests. This routine blood draw will include a pregnancy test for women who are able to have children. To be eligible to take part in this study, the pregnancy test must be negative.
- Additional blood (1 tablespoon) will be drawn to check your thyroid function and the levels of two B vitamins, if these have not been checked within the past 3 months.
- You will have a physical exam, including measurement of vital signs (blood pressure, heart rate, temperature, and breathing rate).
- You will have an electrocardiogram (ECG -- a test that measures the electrical activity of the heart).
- Your resting energy expenditure (energy used at rest) will be measured. with a calorie-measuring device. For this test, you will breathe in and out through your mouth for about 10 minutes to allow a calorie-measuring device to measure the oxygen your body uses, and from this it calculates how much energy your body uses at rest.
- You will be asked to fill out a questionnaire to rate your overall physical well-being, another questionnaire to rate your level of fatigue, and a third questionnaire to rate your experiences with 10 common symptoms in the past 24 hours (pain, fatigue, nausea, depression, anxiety, drowsiness, shortness of breath, changes in appetite, sleep difficulty, and feeling of well being). In total, these questionnaires will take about 30 minutes to complete.
- You will complete a diary entry that lists all of the food and drinks you have had in the last 3 days. It should take about 10 minutes to complete.
- Your strength and stamina will be evaluated. This is measured by hand-grip and pinch strength tests that are done with both hands. These tests will see how hard you can grip a device with your hand and pinch the pads of another device called a pinch gauge. These tests will be done 3 times and your best scores will be used. Your strength and stamina will also be checked using the Get-Up-and-Go test and the 6-minute walk test. The Get-Up-and-Go test measures how long it takes to get up from sitting in a chair that has arms, walking 10 feet, turning around and walking back to the chair, and sitting down. The 6-minute walk test will measure the distance you can walk in 6 minutes on a 100-foot loop. You will walk 50 feet and then turn and walk back to the beginning. You will do this at a walking speed that feels comfortable and for as many times as you can in 6 minutes.
- Blood (1 to 2 tablespoons) will be drawn to check for markers of inflammation and nutrition status.
Study Drug Administration:
You will take one (1) 20mg capsule of melatonin every night. It can be taken with or without food. It should be taken with 8 ounces (1 cup) of water.
You will drink 90 calories of Juven, twice a day. Juven is a powder supplement that is mixed into 8 ounces of water. It is available in orange or grape flavors.
You will also be instructed to increase your daily calorie intake by at least 1,000 calories. To assist you in doing so, dietary advice will be given to you by a nurse or physician.
Exercise Training:
You will complete 2 exercise training sessions a week. The sessions will combine resistance and graded aerobic training.
Resistance training (with Thera-bands) is designed to increase the muscle-building effects of a hormone called testosterone. Thera-bands are rubber bands that you can hold or put around your feet to provide resistance to your muscles when you bend and flex your arms and legs.
You will be instructed in how to do 3 upper-body exercises (chest press, shoulder press, and arm pull down) and 3 lower-body exercises (leg press, leg extension, and leg flexion).
At your first visit, a physician will educate you to make sure that all exercises are done correctly.
Each repetition will take 12 seconds to complete (6 seconds to bend, then 6 seconds to straighten your arm or leg). When 6 repetitions are completed, the next week's set will be increased by 1 repetition.
Graded aerobic exercise is a walking/running program that may help you exercise longer.
Graded aerobic exercise involves walking or running for 3-4 minutes at 70-80% of your maximum predicted heart rate. There will be a 3-minute warm-up and a 3-minute cool-down before and after this exercise.
During your first visit, you will be shown how to monitor your heart rate and how to exercise at 70-80% of your maximum heart rate.
You will add 1 minute to your aerobic exercise at the start of each week.
You will receive your own customized aerobic and resistance exercise program based on your range of motion and risk for falls, which will be evaluated by the study staff.
If you experience chest pain, have a temperature over 100.4 °F, have a platelet count of lower than a certain level, have fresh bruises, or shortness of breath at rest, you will be advised to stop exercising until these are relieved.
Evaluations:
While on study, within 3 days of the days listed below, the following measurements will be monitored:
- Your lean body mass and weight will be checked at Days 15 and 29 using the Tanita TBF-310 body composition analyzer/scale. For measurements with the Tanita TBF 310, you will be asked to wear light clothes and to take off your shoes and socks when being weighed. You will stand on a special scale that will send an extremely low-energy, high-frequency electrical signal from one foot to your other foot. You should not be able to feel this at all.
- Your muscle mass (mid-arm muscle area) will be measured with a special tape.
- The thickness of a skin fold on your triceps (back of your upper arm) will be measured 3 times using skin fold calipers. Calipers are a gentle clamp-like device that is used on the outside of your body to measure skin thickness.
- At Day 29, your resting energy expenditure will be measured.
- On Days 15 and 29 of the study cycle, you will complete the same 3 questionnaires as at screening.
- Your caloric intake will be measured on Days 15 and 29.
- Your strength and stamina will be evaluated on Days 15 and 29.
- On Day 29, blood (1 to 2 tablespoons) will be drawn to check for markers of inflammation and nutrition.
- Blood (about 1 to 2 tablespoons) will be drawn for routine tests every 15 days while you are on-study. You will also have a fecal occult blood test at this time.
Length of Study:
You will be on study for 29 days (1 cycle).
This is an investigational study. Melatonin and Juven are commercially available nutritional supplements and are exempt from FDA approval. However, in patients with cancer and cachexia, the study treatment (resistance training, aerobic exercise, and the use of Juven, and melatonin) is considered experimental. At this time, it is only being used in research.
Up to 40 patients will be enrolled on this study. Up to 30 patients will be enrolled at M.D. Anderson, and 10 will be enrolled at the University of Alabama-Birmingham.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Multimodal Treatment Strategy | Experimental | Behavioral: Graded Resistance Training, Behavioral: Aerobic Exercise, Drug: Melatonin, Dietary Supplement: Juven, Drug: Atenolol, Drug: IbuprofenExercise Program + Pharmacologic Intervention (Melatonin + Atenolol + Ibuprofen) + Nutritional Supplementation (Juven) - Resistance training sessions twice weekly using Thera-bands. Walking or running for 3-4 minutes at 70-80% of maximum predicted heart rate. Melatonin 20 mg by mouth (PO) Daily. 90 calories of Juven, twice a day. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- Are referred to the Cachexia Clinic with involuntary weight loss of >5% of their premorbid weight within the previous 6 months.
- Are 18 years of age or older
- Have a Karnofsky performance score of 60 or higher.
- Can maintain oral food intake during the study
- Can understand the study procedures and can sign an informed consent form.
Key exclusion criteria (9 listed)
- Have dementia or delirium (as determined by the palliative care specialist) at study entry.
- Are pregnant
- Have been taking corticosteroids for longer than 48 hours.
- Have pulmonary edema, ascites or pitting edema on clinical examination.
- Are unable to walk.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Graded Resistance TrainingResistance training sessions twice weekly using Thera-bands. | Behavioural | Multimodal Treatment Strategy |
| Aerobic ExerciseWalking or running for 3-4 minutes at 70-80% of your maximum predicted heart rate. | Behavioural | Multimodal Treatment Strategy |
| Melatonin20 mg by mouth (PO) Daily | Drug | Multimodal Treatment Strategy |
| Juven90 calories of Juven, twice a day. | Dietary supplement | Multimodal Treatment Strategy |
| AtenololAtenolol will only be taken if there's evidence of increased sympathetic activity (resting heart rate >110 beats/min) or resting energy expenditure (REE) > 110% of predicted. | Drug | Multimodal Treatment Strategy |
| IbuprofenIbuprofen 1200mg/day in three divided doses. | Drug | Multimodal Treatment Strategy |
Primary outcome
Participant Gain in Lean Body Mass
Time frame: Baseline to Day 29, approximately 30 days
Measure increases in lean body mass in individuals with cancer who experience cachexia between baseline and day 29 (+/- 3 days).
1 secondary outcome
Improvement of Clinical Outcomes
Time frame: Baseline to Day 29, approximately 30 days
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Feb 2016.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- MD Anderson Cancer CenterLink provided by the sponsor.
Related trials for Advanced Cancer
Active, not recruitingPhase 1/2
A Beta-only IL-2 ImmunoTherapY Study
Advanced Solid Tumor, Unresectable Solid Tumor
RecruitingPhase 1/2
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
Not yet recruitingPhase 2
Low-Dose Apatinib Plus Chemotherapy in ADC-Pretreated HER2-Positive and HER2-Low Advanced Breast Cancer
Breast Neoplasms, Advanced Breast Cancer
RecruitingPhase 2/3
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 2
Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial
Prostate Adenocarcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Rony Dev, DO principal investigator
M.D. Anderson Cancer Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Graded Resistance Training, Aerobic Exercise and Melatonin in people with Advanced Cancer and Cachexia, run by M.D. Anderson Cancer Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 12 Feb 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 12 Feb 2016). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Participant Gain in Lean Body Mass (time frame: Baseline to Day 29, approximately 30 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2016.